Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Immunodeficiencies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT03617198
What this trial is testing

CD4 CAR+ ZFN-modified T Cells in HIV Therapy

Who this might be right for
Hiv
University of Pennsylvania 12
Testing effectiveness (Phase 2)Study completedNCT01327898
What this trial is testing

Risk Reduction for Urban Substance Using Men Who Have Sex With Men (MSM)

Who this might be right for
HIV InfectionSubstance Abuse
Nova Southeastern University 515
Not applicableStudy completedNCT02926456
What this trial is testing

Study in HIV1-Positive, Virosuppressed Patients Currently inTreatment With Ritonavir-Boosted Protease Inhibitors (PI/r) Starting Cobicistat-Boosted Darunavir (DRV/c - Rezolsta)

Who this might be right for
Human Immunodeficiency Virus
Janssen-Cilag S.p.A. 337
Large-scale testing (Phase 3)Study completedNCT01252212
What this trial is testing

Adherence, Improvement Measure (AIM) System

Who this might be right for
Patient ComplianceAIDS
University of California, San Francisco 99
Post-approval studies (Phase 4)Ended earlyNCT01014481
What this trial is testing

Appropriate Timing of HAART in Co-infected HIV/TB Patients

Who this might be right for
HIV InfectionsTuberculosis
Bamrasnaradura Infectious Diseases Institute 156
Testing effectiveness (Phase 2)Study completedNCT03208231
What this trial is testing

Evaluating the Safety and Antiviral Activity of Monoclonal Antibody VRC01 in Infants With HIV Receiving Combination Antiretroviral Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 61
Testing effectiveness (Phase 2)Study completedNCT03296553
What this trial is testing

Impact of Valganciclovir on Severe IRIS-Kaposi Sarcoma Mortality: an Open-label, Parallel, Randomized Controlled-trial.

Who this might be right for
Kaposi SarcomaHuman Immunodeficiency VirusImmune Reconstitution Syndrome
National Institute of Cancerología 40
Not applicableWithdrawnNCT04305977
What this trial is testing

Writing to Alleviate Violence Exposure for Transgender Women (WAVE-TW)

Who this might be right for
PTSDDepressionVirus, Human Immunodeficiency
University of Miami
Post-approval studies (Phase 4)Study completedNCT00885664
What this trial is testing

Immune Reconstitution as a Determinant of Adverse Effects to New Antiretroviral Therapy in Persons With Advanced HIV Infection

Who this might be right for
HIV Infections
University of Cincinnati 60
Not applicableStudy completedNCT00360932
What this trial is testing

Facial Lipoatrophy Correction Experience With SCULPTRA ("FACES" Study)

Who this might be right for
Facial Lipoatrophy
Bausch Health Americas, Inc. 290
Not applicableStudy completedNCT00002132
What this trial is testing

Randomized, Controlled, Double-Blind Study of Itraconazole Oral Solution Versus Fluconazole Tablets for the Treatment of Esophageal Candidiasis.

Who this might be right for
Candidiasis, EsophagealHIV Infections
Janssen Pharmaceuticals
Early research (Phase 1)Study completedNCT00545987
What this trial is testing

Study of a Potential Preventive Vaccine Against HIV in Healthy Volunteers

Who this might be right for
HIV Infections
Rockefeller University 40
Not applicableStudy completedNCT05938621
What this trial is testing

Estamos Juntos (We Are Together): Improving HIV Care Delivery by Capacitating Health Care Providers

Who this might be right for
Hiv
Vanderbilt University Medical Center 28,448
Early research (Phase 1)Study completedNCT04563845
What this trial is testing

Effect of Therapeutic and Supratherapeutic Oral Doses of GSK3640254 on Cardiac Conduction Compared to Placebo and a Single Oral Dose of Moxifloxacin

Who this might be right for
HIV Infections
ViiV Healthcare 50
Not applicableLooking for participantsNCT06370481
What this trial is testing

HIV, Equity, and Addiction Training (HEAT) Program

Who this might be right for
Substance Use DisordersHivOpioid Use Disorder+1 more
University of Alabama at Birmingham 30
Not applicableAvailableNCT06731036
What this trial is testing

Expanded Access to CD34+ Selection Utilizing Miltenyi CliniMACS Prodigy® for Patients Receiving Peripheral Blood Stem Cell Transplantations and Stem Cell Boosts

Who this might be right for
Severe Combined ImmunodeficiencyFanconi AnemiaDyskeratosis Congenita+1 more
University of Florida
Not applicableStudy completedNCT01775436
What this trial is testing

Palliative Care in People Living With HIV/AIDS: Integrating Into Standard of Care

Who this might be right for
HIV
Children's National Research Institute 444
Not applicableStudy completedNCT01048671
What this trial is testing

Management of Human Immunodeficiency Virus 1 (HIV-1) Participants Treated With Antiretroviral (ARV) Combination Therapy Including Raltegravir (MK-0518-138)

Who this might be right for
HIV Infections
Merck Sharp & Dohme LLC 482
Not applicableStudy completedNCT00001071
What this trial is testing

Stem Cells and Filgrastim

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 24
Post-approval studies (Phase 4)Study completedNCT00068809
What this trial is testing

4-Day-A-Week Treatment Plan for HIV Infected Adolescents

Who this might be right for
HIV Infections
University of North Carolina, Chapel Hill 31
Next Page